Ervaoffine E (1), a new pseudoindoxyl alkaloid possessing a unique rearranged 1,4-diazacycloheptane skeleton, ervaoffine F (2), the first 5,6-seco-6-nor iboga-type alkaloid featuring ring C cleavage, and ervaoffine G (3), bearing an unusual contracted valerolactam ring, together with six known alkaloids were isolated from Ervatamia officinalis. Their structures and absolute configurations were determined by extensive spectroscopic analysis, single-crystal X-ray diffraction and quantum chemical ECD calculations. Plausible biogenetic pathways of these new alkaloids were also proposed and provided new insights into the structural plasticity of ring C in iboga-type alkaloids. Compound 3 exhibited a significant neuroprotective effect against oxygen-glucose deprivation (OGD)-induced damage of cultured cortical neurons, an in vitro model of ischemic stroke.
Introduction
Iboga-type alkaloids are a special class of monoterpenoid indole alkaloids that generally display a characteristic indole fused with an isoquinuclidine unit by a seven-membered azepane ring (ring C). 1 Iboga-type alkaloids also exhibit a wide range of biological activities, such as anti-addiction, anti-acetylcholinesterase and antitumor activities. 2 The complex scaffolds, multiple stereogenic centers and promising biological effects of the iboga-type alkaloids make them challenging targets for congurational assignment and total synthesis. 3 The plant Ervatamia officinalis (Apocynaceae), a rich source of iboga-type alkaloids, is distributed in the Guangdong and Hainan provinces of China and has been used as a folk medicine for the treatment of stomachaches, snakebites, and hypertension. 4 Our previous chemical investigations on the genus Ervatamia has led to the isolation of a number of iboga-type alkaloids, some of which possessed novel structures and showed neuroprotective activity or in vitro cytotoxicity. 5 Through our continuing investigation, three novel alkaloids, ervaoffines E-G (1-3), and six putative biosynthetic relative iboga-type alkaloids are herein reported from the twigs and leaves of E. officinalis (Fig. 1) . Structurally, compound 1 features a unique rearranged 1,4-diazacycloheptane ring C that fuses the pseudoindoxyl and isoquinuclidine units, forming an unprecedented 6/5/7/6/6 pentacyclic ring system with seven chiral centers. Compound 2 is the rst example of 5,6-seco-6-nor iboga-type alkaloid with ring C cleavage, and 3 presents an unusual contracted valerolactam ring C. Intriguingly, these special structural features, highlighted by ring C cleavage and reconstructions, reveal the high structural plasticity of iboga-type alkaloids. Furthermore, 3 shows signicant neuroprotective effects against oxygen-glucose deprivation (OGD)-induced damage of cultured cortical neurons, an in vitro model of ischemic stroke. 6 Herein, the isolation, structural elucidation, and neuroprotective activity evaluation of 1-9 are described. In addition, the hypothetical biogenetic pathways of the new molecules are presented. 13 C NMR and DEPT spectra of 1 revealed the presence of twenty carbon signals, including one carbonyl, six olenic carbons, one quaternary carbon, six methines, four methylenes, and two methyls. The above data implied that 1 was a pseudoindoxyl alkaloid. Detailed analysis of the 1 H-1 H COSY, HSQC, HMBC and NOESY spectra resulted in the unambiguous assignment of all the 1 H and 13 C NMR signals of 1, as shown in Table 1 . The 1 H-1 H COSY spectrum of 1 established the presence of three spin coupling systems shown in bold in Fig. 2 , indicating the presence of an ethyl-substituted isoquinuclidine unit. The HMBC correlations between H-6 and C-2/C-13, between H-16 and C-7, and between H 2 -17 and C-2 as well as the correlation between H-21 and C-3/C-5/C-17/C-19 revealed that the pseudoindoxyl moiety and the isoquinuclidine unit were fused by a 1,4-diazacycloheptane framework. Moreover, C-3 and C-6 were connected by an oxygen atom to form a 1,3-oxazolidine moiety, which was deduced from the HMBC correlations between H-3 and C-5/C-6 as well as from the molecular formula of 1. To provide direct conrmation for the position and conguration of the hydroxyl group in 1, the 1D and 2D NMR spectra of 1 were also recorded in DMSO-d 6 . The HMBC correlations (in DMSOd 6 ) between the hydroxyl group [d H 6.39 (1H, br s)] and C-7/C-16 veried that the hydroxyl was attached to the C-2 position.
Results and discussion
Further interpretation of the HMBC correlations allowed the establishment of the planar structure of 1 (Fig. 2 ). In the NOESY spectrum (in DMSO-d 6 ) , correlations between H-20 and H-15b/ H-16 suggested that these protons were cofacial and assigned as being b-orientated. The NOE correlations between H-3 and H-5a/H-15a and between H-6 and H-12 indicated that these protons were a-oriented. The b-orientation of 2-OH was supported by the NOE correlations between 2-OH and H-5b/H-16/H-21 ( Fig. 3 ). The absolute conguration of 1 was established by the comparison of the calculated electronic circular dichroism (ECD) spectra of its two enantiomers with the experimental spectra. The good agreement of the calculated ECD curve of (2R,3S,6S,14R,16R,20S,21S)-1 with the experimental ECD spectrum of 1 unequivocally proved the absolute conguration of 1 ( Fig. 4) . Thus, the structure of 1 was elucidated, and this compound was named ervaoffine E. The molecular formula of C 19 H 24 N 2 O 2 for 2 was established by its HRESIMS data (m/z 335.1733 [M + Na] + , calcd for C 19 H 24 N 2 O 2 Na: 335.1730). The UV spectrum of 2 revealed absorption maxima at 204 and 271 nm. The IR spectrum displayed absorption bands for a carbonyl group (1651 cm À1 ) and an aromatic ring (1541, 1488 cm À1 ). Comparison of the NMR data of 2 with those of 6-oxo-ibogaine (6) suggested their similarity, except for the existence of signals for a formyl group [d H 7.55 (1H, s); d C 164.8] and an olenic methine [d H 6.15 (1H, s); d C 99.9] as well as the absence of resonances for a keto group, a quaternary olenic carbon and a methylene ( Table 1 ). The 1 H-1 H COSY correlations of 2 further conrmed the presence of an ethyl-substituted isoquinuclidine unit (Fig. 2 ). In the HMBC spectrum, cross peaks between H-21 and C-2/C-3/C-17 and between H-16 and C-7/C-20 indicated that the isoquinuclidine unit and the indole ring were connected via a C-2-C-16 bond. Furthermore, the HMBC correlations between H-21 and C-5 conrmed that the aldehyde group was attached to the N-4 position. The relative conguration of 2 could be assigned through its NOESY spectrum, the NOE correlations between H-7 and H-3a/H-9/H-17b suggested that these protons were cofacial, while the correlations between H-16 and H-17a/H-20, and between H-20 and H-15a indicated that H-15a, H-16, H-17a and H-20 were on the opposite face ( Fig. 3) . The absolute conguration of 2 was proved by a single-crystal X-ray diffraction experiment using CuKa radiation at 100 K [Flack parameter: 0.00(7)] ( Fig. 5) . Additionally, the calculated ECD curve of 14R,16R,20S,21S-2 matched well with its experimental ECD spectrum ( Fig. 4) , which was consistent with the X-ray crystallographic analysis of 2.
The molecular formula of 3 was deduced by HRESIMS analysis as C 20 H 22 N 2 O 3 by the quasi-molecular ion at m/z 339.1703 [M + H] + (calcd for C 20 H 23 N 2 O 3 : 339.1702). The IR spectrum of 3 showed the presence of carbonyl groups (1739, 1635 cm À1 ) and an aromatic ring (1583 and 1457 cm À1 ). The NMR data of 3 were in good agreement with those of 9, except for an upeld shi of a quaternary olenic carbon (C-2) and a methyne (C-21) as well as the absence of resonances for a methylene in 3, suggesting that 3 was an unusual iboga-type alkaloid with one less carbon. Detailed interpretation of the 1 H-1 H COSY, HSQC, and HMBC data for 3 allowed the conrmation of its planar structure (Fig. 2) . The valerolactam ring of 3 was veried by the key HMBC correlations between H-9 and C-7 and between H-21 and C-2/C-3/C-15/C-17 as well as the correlation between H-3 and C-6. The NOESY spectrum of 3 displayed signicant NOE cross peaks between H-3a and H-17b, and between H-3b and H-15b, indicating that H-15b and H-17b were on the same face. Nevertheless, H-20 was on the opposite side, which was deduced by the NOE cross peaks between H-15a and H-17a/H-20 ( Fig. S12 †) . Finally, the absolute conguration of 3 was elucidated to be 14R,16S,20S,21S based on the comparison between the experimental and calculated ECD data (Fig. 4) .
Six known iboga-type alkaloids lirofoline A (4), 7 lirofoline B (5), 7 6-oxo-ibogaine (6), 8 8-oxo-ibogaine lactam (7), 9 coronaridine (8) 10 and 5-oxo-coronaridine (9) 11 were identied by the comparison of their physical and spectroscopic data with those reported in the literature. It is worth mentioning that the absolute conguration of 4 was determined for the rst time by X-ray diffraction analysis with a suitable Flack parameter of À0.03 (7) using CuKa radiation (Fig. S10 †) . Plausible biosynthetic pathways of compounds 1-3 were shown in Scheme 1. Ibogaine (10) 12 and coronaridine (8) 10 are common constituents of the plant E. officinalis that could be hydroxylated and then protonated to yield intermediates A1 and B1, respectively. A1 could be further dehydrated to afford C1. Subsequently, oxidation of C1 resulted in cleavage of the C-6-C-7 bond to afford C2, which was followed by an intramolecular nucleophilic addition between the amino group (N-1) and aldehyde group (C-6) to form the N-1-C-6 bond and then by a Polonovski-type reaction 13 to generate 1. The dehydration reactions of A1 and B1 coupled with electron transfer could give A2 and 5,6-dehydrocoronaridine (11), 14 respectively. Similarly, oxidative cleavage of the C-5-C-6 bonds in A2 and 11 gave A3 and B3, respectively. Loss of the C-6 aldehyde group in A3 led to 2 through a decarboxylation reaction mechanism, whereas the loss of C-5 in B3 produced 3 aer oxidation and amidation reactions.
All the isolated alkaloids were tested for their neuroprotective effects against OGD-induced damage of cultured cortical neurons, an in vitro model of ischemic stroke. The result showed that compound 3 had a signicant protective effect (Fig. 6 ), which indicates that 3 may be potentially bene-cial for treating ischemic stroke.
Conclusions
To sum up, three new iboga-type alkaloids (1-3) and six known ones were isolated from E. officinalis. Among them, 1 possessed an unprecedented 6/5/7/6/6 pentacyclic ring system. 2 was the rst 5,6-seco-6-nor iboga-type alkaloid and 3 featured an unusual contracted valerolactam ring. In particular, plausible biogenetic pathways of these novel alkaloids have expanded the structural plasticity of iboga-type alkaloids featuring cleavage and rearrangement of ring C. Furthermore, compound 3 showed a signicant protective effect against OGD-induced damage of cultured cortical neurons, which may provide a new potential candidate for treating ischemic stroke.
Experimental

General experimental procedures
Melting points were measured using an X-5 micro melting point apparatus (uncorrected). UV data were recorded using a JASCO V-550 UV/Vis spectrophotometer. Optical rotations were determined using a JASCO P-1020 digital polarimeter at 25 C. ECD data were measured with a JASCO J-810 spectrometer. IR spectra were obtained by a JASCO FT/IR-480 Plus infrared spectrometer using KBr pellets. HRESIMS was performed on an Agilent 6210 ESI-TOF mass spectrometer. ESIMS data were measured on a Thermo Finnigan LCQ Advantage MAX mass spectrometer (Thermo Fisher Scientic Inc, USA). NMR spectra were acquired using Bruker AV-600 and AV-400 spectrometers. X-ray crystallographic data were obtained using an Agilent Gemini S Ultra diffractometer and Cu Ka radiation. Column chromatography (CC) was performed utilizing Sephadex LH-20 (Pharmacia Biotech AB, Uppsala, Sweden), silica gel (200-300 mesh; Qingdao Marine Chemical Inc., Qingdao, P. R. China), and ODS (YMC, Kyoto, Japan). Preparative HPLC (pHPLC) was carried out on an Agilent 1260 system (equipped with a G1310B Iso pump and G1365D MWD VL detector) with a Waters Xbridge™ C 18 OBD reversed-phase column (19 Â 250 mm, 5 mm, USA). 
Plant material
Extraction and isolation
The powdered twigs and leaves of E. officinalis (18.0 kg) were percolated at room temperature with 95% EtOH (24 h Â 6) to afford a residue (0.8 kg) aer evaporation, that was treated with 0.5% hydrochloric acid to adjust the pH to 3 and then extracted with CHCl 3 . The acidic aqueous phase was basied with aqueous ammonia to pH 9-10 and partitioned with CHCl 3 to obtain a total alkaloid fraction (65.3 g), which was subjected to silica gel CC and eluted with CHCl 3 -MeOH (10 : 0 to 0 : 10, v/v) to obtain twelve fractions (Frs 1-12). Fr. 1 was rechromatographed by silica gel CC and eluted with cyclohexane-acetone (10 : 0 to 0 : 10, v/v) to afford 5 subfractions (A-E). Fr. 1C was subjected to pHPLC using MeCN-H 2 O-Et 2 NH (7 : 3 : 0.001, v/v) as the mobile phase to yield compounds 3 (2.8 mg, t R ¼ 28.4 min) and 9 (6.2 mg, t R ¼ 24.0 min). Fr. 2 was successively subjected to Sephadex LH-20 using CHCl 3 -MeOH (1 : 1, v/v) as the eluent and puried by pHPLC using MeOH-H 2 O-Et 2 NH (7.3 : 2.7 : 0.001, v/v) to yield compounds 4 (15.0 mg, t R ¼ 32.9 min), 5 (6.0 mg, t R ¼ 29.4 min) and 8 (30.0 mg, t R ¼ 64.4 min). Fr. 3 was chromatographed on an ODS column using MeOH-H 2 O (3 : 7 to 10 : 0, v/v) as the eluent, followed by pHPLC using MeOH-H 2 O-Et 2 NH (7 : 3 : 0.001, v/v) as the mobile phase to afford compound 1 (7.0 mg, t R ¼ 36.3 min). Fr. 5 was successively separated on Sephadex LH-20 CC Fig. 6 Effects of compounds 1-9 on cell viability of cultured cortical neurons. The cortical neurons were treated with different alkaloids at 12.5, 25, 50 and 100 mM, and cell viability was determined by MTT assay. Neuroserpin (20 ng mL À1 ) served as a positive control. Data are shown as the mean AE SEM of three experiments. ### P < 0.001, control vs. DMSO, *P < 0.05, compounds 1-9 or neuroserpin vs. DMSO. Oneway ANOVA followed by Bonferroni's multiple comparison test.
using CHCl 3 -MeOH (1 : 2, v/v) as the eluent and further puried by pHPLC (MeOH-H 2 O-Et 2 NH, 6.5 : 3.5 : 0.001, v/v) to afford compound 2 (4.0 mg, t R ¼ 44.4 min). Fr. 6 was separated by repeated Sephadex LH-20 CC (MeOH) and puried by pHPLC (MeCN-H 2 O-Et 2 NH, 5 : 5 : 0.001, v/v) to obtain compounds 6 (2.3 mg, t R ¼ 40.2 min) and 7 (3.8 mg, t R ¼ 26.1 min).
Structure characterization
Ervaoffine E (1). Bright yellow oil; [a] 25 D +23.1 (c 0.77, MeOH); UV (MeOH) l max (log 3) 232 (4.88), 426 (4.01) nm; ECD (MeOH) l max (D3) 428.6 (À6.9), 339.1 (+4.3), 269.6 (À2.0), 240.9 (+15.8), 225.4 (+17.6) nm; IR (KBr) n max 3421, 2954, 2931, 2873, 1706, 1623, 1493, 1455, 1336, 1285, 1232, 1117 
X-ray crystallographic analysis
The structures were solved by direct methods and rened by full-matrix least-squares on F 2 using SHELXL-97 package soware. 15 were collected for the analysis. Final R ¼ 0.0291 and R w ¼ 0.0737, and the goodness of t on F 2 was equal to 1.092; Flack parameter ¼ À0.03 (7) .
Neuronal culture and measurement of cell viability
The cortical neurons were collected from Sprague-Dawley rats within embryo. 16 Briey, the cortical neurons were dissociated by incubation for 15 min at 37 C in 4 mL of 0.125% trypsin. Dissociated neurons were fed with Neurobasal medium (Life Technologies) supplemented with 2% B27 (Life Technologies). Neuronal cells were seeded on 96-well dishes (1 Â 10 5 per well), which was precoated with poly-L-lysine (0.1 mg mL À1 , Sigma) for 24 h at 37 C. The cell medium was changed every 72 h. The cells were cultured for 7 d before experiments. The isolated alkaloids were dissolved in DMSO (Sigma) and were prepared from a 50 mM L À1 stock solution immediately before use. All the compounds were then diluted in culture medium to the indicated nal concentrations. The compounds were added to the cortical neurons for 4 h as pretreatment. The medium was replaced with glucose-free DMEM (Life Technologies), and the cultures were incubated in a hypoxia-chamber under a saturated atmosphere of 95% N 2 and 5% CO 2 for 4 h, followed by reoxygenation under normal culture conditions for 24 h. Cell survival was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5diphenyltetrazolium bromide (MTT, Sigma) assay. 17 Briey, MTT solution (nal concentration of 5 mg mL À1 ) was added to each well for 4 h at 37 C. Subsequently, the dark blue formazan crystals formed in intact cells were solubilized with 100 mL DMSO. Aer shaking at room temperature for 10 min, absorbance at 595 nm was measured with a DTX880 multimode detector (Beckman Coulter, Brea, CA, USA). Cell viability was expressed as a percentage of the non-treated control. GraphPad Prism 5.0 soware was used to perform statistical analysis. All experimental procedures involving the use of animals were approved by the Ethics Committee on Animal Experiments at Jinan University, China, and were strictly performed according to the guidelines of the Care and Use of Laboratory Animals. All efforts were made to minimize the suffering and the number of animals used.
